Evaluation of mizoribine as an immunosuppressant in subrenal capsule assay using immunocompetent mice. 1990

D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
Department of Clinical Cancer Chemotherapy, Tohoku University, Sendai.

We studied the application of mizoribine (MZR) to normal immunocompetent mice in subrenal capsule assay (SRCA) by means of tumor growth curve determination, histological analysis and autoradiography. At 400 mg/kg, MZR prolonged the actual tumor growth and moderately reduced the host reaction. Doses below 200 mg/kg did not effectively suppress the host reaction. The maximal weight loss of mice in the 400 mg/kg group reached 29%, but did not exceed 10% within 8 days. Hence, we applied 400 mg/kg of MZR to SRCA for up to eight days for cancer chemotherapy testing. This dose of MZR did not affect the labeling index of tumor cells compared with the control.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)

Related Publications

D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
January 1989, Zentralblatt fur Gynakologie,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
March 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
August 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
April 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
August 1987, European journal of cancer & clinical oncology,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
September 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
April 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
August 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
August 1987, Gan to kagaku ryoho. Cancer & chemotherapy,
D Y Chen, and H Kikuchi, and M Asamura, and M Gamoh, and A Wakui
January 1990, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!